With some people accessing these medications outside of the NHS, traditional systems for understanding usage (e.g
doi: 10.1002/cncr.20454 75 BjrndahlMCaoRNissenLJClasperSJohnsonLAXueYet al
Methods Qualitative, individual, semi-structured interviews were conducted in nine participants who were prescribed GLP-1 receptor agonists for the treatment of obesity and/or T2D
Telehealth platforms, patient communities, and healthcare providers have collected outcomes data from patients using compounded GLP-1 medications, including weight loss trajectories, side effect frequencies, and treatment satisfaction scores
It also shows an enhancement in physical performance, While this evidence is very promising, its still early in the research process
doi: 10.1016/j.biopsych.2014.10.014 17 BoldriniM.UnderwoodM